The SafeBoosC-III trial and the future of cerebral oximetry-guided interventions in preterm infants-time to pause and reset?
作者信息
Dummula Krishna, Pandey Vishal, Sampath Venkatesh
机构信息
Division of Neonatology, Children's Mercy Hospital, Kansas City, MO, USA.
Department of Pediatrics, University of Kansas School of Medicine, Kansas City, KS, USA.
出版信息
Transl Pediatr. 2024 Jun 30;13(6):1017-1021. doi: 10.21037/tp-24-89. Epub 2024 Jun 27.
Abstract
摘要
相似文献
1
The SafeBoosC-III trial and the future of cerebral oximetry-guided interventions in preterm infants-time to pause and reset?
Transl Pediatr. 2024 Jun 30;13(6):1017-1021. doi: 10.21037/tp-24-89. Epub 2024 Jun 27.
2
Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial.
Trials. 2019 Dec 30;20(1):811. doi: 10.1186/s13063-019-3955-6.
3
A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial.
Trials. 2013 May 1;14:120. doi: 10.1186/1745-6215-14-120.
4
Cerebral Oximetry in the Neonatal Intensive Care Unit: Discussion of Two Contradicting Study Results (SafeBoosC-II, SafeBoosC-III).
Adv Exp Med Biol. 2024;1463:41-44. doi: 10.1007/978-3-031-67458-7_7.
5
Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial.
Trials. 2023 Oct 7;24(1):653. doi: 10.1186/s13063-023-07653-x.
6
Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants.
Trials. 2023 Nov 16;24(1):737. doi: 10.1186/s13063-023-07720-3.
7
Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants.
Trials. 2019 Dec 19;20(1):746. doi: 10.1186/s13063-019-3756-y.
8
The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trial.
Trials. 2023 Oct 28;24(1):696. doi: 10.1186/s13063-023-07699-x.
9
Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III.
Trials. 2020 Apr 23;21(1):356. doi: 10.1186/s13063-020-4206-6.
10
Effect of Cerebral Oximetry-Guided Treatment on Brain Injury in Preterm Infants as Assessed by Magnetic Resonance Imaging at Term Equivalent Age: An Ancillary SafeBoosC-III Study.
Neonatology. 2025;122(1):38-45. doi: 10.1159/000539175. Epub 2024 Jun 21.
本文引用的文献
1
Tissue Oxygenation Changes After Transfusion and Outcomes in Preterm Infants: A Secondary Near-Infrared Spectroscopy Study of the Transfusion of Prematures Randomized Clinical Trial (TOP NIRS).
JAMA Netw Open. 2023 Sep 5;6(9):e2334889. doi: 10.1001/jamanetworkopen.2023.34889.
2
Cerebral Oximetry Monitoring in Extremely Preterm Infants.
N Engl J Med. 2023 Apr 20;388(16):1501-1511. doi: 10.1056/NEJMoa2207554.
3
Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): multicentre randomised phase 3 clinical trial.
BMJ. 2023 Jan 24;380:e072313. doi: 10.1136/bmj-2022-072313.
4
Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial.
PLoS One. 2022 Jan 24;17(1):e0262640. doi: 10.1371/journal.pone.0262640. eCollection 2022.
5
Preventing Brain Injury in the Preterm Infant-Current Controversies and Potential Therapies.
Int J Mol Sci. 2021 Feb 7;22(4):1671. doi: 10.3390/ijms22041671.
6
Neuroprotection Care Bundle Implementation to Decrease Acute Brain Injury in Preterm Infants.
Pediatr Neurol. 2020 Sep;110:42-48. doi: 10.1016/j.pediatrneurol.2020.04.016. Epub 2020 May 1.
7
Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III.
Trials. 2020 Apr 23;21(1):356. doi: 10.1186/s13063-020-4206-6.
8
Near-Infrared Spectroscopy in Pediatric Congenital Heart Disease.
J Cardiothorac Vasc Anesth. 2020 Feb;34(2):489-500. doi: 10.1053/j.jvca.2019.08.048. Epub 2019 Sep 3.
9
Continuous vital sign analysis for predicting and preventing neonatal diseases in the twenty-first century: big data to the forefront.
Pediatr Res. 2020 Jan;87(2):210-220. doi: 10.1038/s41390-019-0527-0. Epub 2019 Aug 4.
10
No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life.
Acta Paediatr. 2019 Feb;108(2):275-281. doi: 10.1111/apa.14463. Epub 2018 Jul 5.
Zotero 插件